Gene · 8815
BANF1: barrier to autointegration nuclear assembly factor 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. BANF1: barrier to autointegration nuclear assembly factor 1. Genes, record 8815. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/8815
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O75531 | Barrier-to-autointegration factor | 89 | 29 | Ensembl, GeneID, HGNC |
Source UniProt
Patents40
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 38612 | O75531 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38613 | O75531 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38614 | O75531 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38616 | O75531 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 4682 | O75531 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 4682 | O75531 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 8292 | O75531 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 8293 | O75531 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 8295 | O75531 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 8296 | O75531 | Espacenet |
1 to 10 of 40
See all 40 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,457
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | BANF1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 27 | 2025 |
| R01CA163915 | ATP-Dependent Chromatin Remodeling in Human Malignancy | 19 | 2025 |
| ZIAHL005801 | Genome-wide analysis of chromatin modifications | 12 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 11 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 10 | 2025 |
| R01CA097098 | Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer | 10 | 2025 |
| ZIAES071006 | Epigenetic and Transcriptional Functions of Nuclear Receptors and Chromatin Remodeling Proteins in Stem and Cancer Cells | 9 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 8 | 2025 |
| R01CA113794 | The function of Snf5 (SMARCB1), an epigenetic tumor suppressor | 8 | 2025 |
| R01CA172152 | Role of the SWI/SNF complex in tumor suppression | 8 | 2025 |
1 to 10 of 2,457Source NIH's project files
See all 2,457 nih grantsPapers2,964
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Thoracic Aortic Disease in Genetic Syndromes Beyond Established Aortopathy Genes. | medRxiv | 2026 | 42818859 | PubTator, text mining | PubMed |
| AR-V7 Utilizes a Noncanonical Nuclear Localization Signal to Sustain Androgen-Independent Nuclear Import and Signaling. | bioRxiv | 2026 | 42818066 | PubTator, text mining | PubMed |
| A guide to selecting high-performing antibodies for ARID1B (UniProt ID: Q8NFD5) for use in western blot and immunoprecipitation. | F1000Res | 2026 | 42806975 | PubTator, text mining | PubMed |
| Müllerian Duct Aplasia in a Girl With SMARCB1-Related Coffin-Siris Syndrome: A Rare Co-Occurring Anomaly. | Clin Genet | 2026 | 42805767 | PubTator, text mining | PubMed |
| CRISPR-Enabled functional genomics in hPSCs-derived neural models for autism spectrum disorder. | Metab Brain Dis | 2026 | 42747551 | PubTator, text mining | PubMed |
| Mitochondrial ATP promotes T cell differentiation through chromatin accessibility. | Cell | 2026 | 42727574 | PubTator, text mining | PubMed |
| African swine fever virus A151R protein antagonizes the antiviral activity of barrier-to-autointegration factor (BAF) by targeting its dsDNA-binding activity. | J Virol | 2026 | 42725733 | PubTator, text mining | PubMed |
| SWI/SNF Alterations Define a Chromatin-Dependent Subtype of Urothelial Carcinoma. | bioRxiv | 2026 | 42620113 | PubTator, text mining | PubMed |
| Defective microhomology-mediated end joining in SMARCB1-deficient tumors. | Sci Adv | 2026 | 42600026 | PubTator, text mining | PubMed |
| BRG1/BRM-associated factor chromatin remodeling complexes in cardiovascular disease: Mechanisms and therapeutic opportunities. | Int J Biol Macromol | 2026 | 42571864 | PubTator, text mining | PubMed |
1 to 10 of 2,964
See all 2,964 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/8815
GET https://conductscience.org/api/genes/v1/8815/patents?page=2